We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current HUMA market cap is 534.9M. The company's latest EPS is USD -0.8802 and P/E is -12.45.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -22.51M | -26.73M | -24.62M | -26.18M | -26.58M |
Net Income | -36.97M | -22.71M | -26M | -25.11M | -31.9M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 0 | 1.26M | 1.57M | 0 |
Operating Income | -249k | -81.26M | -84.58M | -100.05M |
Net Income | -233k | -26.48M | -11.97M | -110.78M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Total Assets | 182.98M | 168.11M | 149.39M | 128.22M | 161.47M |
Total Liabilities | 101.09M | 106.99M | 112.39M | 114.68M | 135.31M |
Total Equity | 81.89M | 61.12M | 36.99M | 13.55M | 26.15M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 101.26M | 286.53M | 204.3M | 128.22M |
Total Liabilities | 2.1M | 164.36M | 87.37M | 114.68M |
Total Equity | 5M | 122.17M | 116.93M | 13.55M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | ||
Operating | -18.64M | -41.24M | -54.25M | -73.31M | -27.35M |
Investing | -1.15M | 470k | -23k | -173k | -391k |
Financing | -409k | 5.61M | 4.84M | 4.51M | 62.8M |
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -245k | -81.19M | -71.13M | -73.31M |
Investing | -100M | -8.22M | 4.85M | -173k |
Financing | 101.34M | 266.98M | -1.45M | 4.51M |
Market Cap | 534.9M |
Price to Earnings Ratio | -12.45 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 17.15 |
Price to Book Ratio | 101.83 |
Dividend Yield | - |
Shares Outstanding | 125.86M |
Average Volume (1 week) | 2.36M |
Average Volume (1 Month) | 3.3M |
52 Week Change | 58.58% |
52 Week High | 9.97 |
52 Week Low | 2.4512 |
Spread (Intraday) | 0.12 (2.81%) |
Company Name | Humacyte Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.humacyte.com |
Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions